Sergej Konoplev
- Hematology top 0.2%
- Oncology top 2%
- Molecular Biology top 5%
- Genetics top 0.5%
- Immunology top 2%
- Co-authors
- L. Jeffrey MedeirosMarina KonoplevaMichael AndreeffHagop M. KantarjianCarlos E. Bueso‐RamosJeffrey L. JorgensenPei LinA.Yu. Zaritskey
- Topics
- Acute Myeloid Leukemia Research (55 papers)Lymphoma Diagnosis and Treatment (43 papers)Chronic Lymphocytic Leukemia Research (34 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesChinaRussia
In The Last Decade
Sergej Konoplev
146 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 101
- Hematology 2.2k
- Oncology 1.4k
- Molecular Biology 1.4k
- Genetics 1.2k
- Immunology 1.1k
Countries citing papers authored by Sergej Konoplev
This map shows the geographic impact of Sergej Konoplev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergej Konoplev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergej Konoplev more than expected).
Fields of papers citing papers by Sergej Konoplev
This network shows the impact of papers produced by Sergej Konoplev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergej Konoplev. The network helps show where Sergej Konoplev may publish in the future.
Co-authorship network of co-authors of Sergej Konoplev
This figure shows the co-authorship network connecting the top 25 collaborators of Sergej Konoplev. A scholar is included among the top collaborators of Sergej Konoplev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergej Konoplev. Sergej Konoplev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 16 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 5 | |
| 6 | 54 | |
| 7 | 10 | |
| 8 | 8 | |
| 9 | 16 | |
| 10 | 24 | |
| 11 | 5 | |
| 12 | 2 | |
| 13 | 95 | |
| 14 | 24 | |
| 15 | 197 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 397 | |
| 19 | Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies | 4 |
| 20 | HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation. | 33 |
About Sergej Konoplev
Sergej Konoplev is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 154 papers that have together received 4.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (43 papers) and Chronic Lymphocytic Leukemia Research (34 papers). The work is most often cited by research in Hematology (2.2k citations), Genetics (1.2k citations) and Pathology and Forensic Medicine (964 citations). Sergej Konoplev has collaborated with scholars based in United States, China and Russia. Frequent co-authors include L. Jeffrey Medeiros, Marina Konopleva, Michael Andreeff, Hagop M. Kantarjian, Carlos E. Bueso‐Ramos, Jeffrey L. Jorgensen, Pei Lin, A.Yu. Zaritskey, Wei Hu and C. Cameron Yin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.